Case report: Treatment of metastatic dedifferentiated chondrosarcoma with pembrolizumab yields sustained complete response

Dedifferentiated chondrosarcomas (DDCS) are aggressive tumors with poor outcomes. Treatment of localized DDCS is primarily surgical, though most patients present with unresectable or metastatic disease. Systemic treatment options for advanced DDCS are limited, and the benefits of chemotherapy in thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Amisha, Thorpe, Steven W., Darrow, Morgan, Carr-Ascher, Janai R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713241/
https://www.ncbi.nlm.nih.gov/pubmed/36465334
http://dx.doi.org/10.3389/fonc.2022.991724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713241/
https://www.ncbi.nlm.nih.gov/pubmed/36465334
http://dx.doi.org/10.3389/fonc.2022.991724

Ejemplares similares